发明名称 Neue Naphthochinone und ihre Anwendung als Arzneimittel
摘要 The present invention relates to the use of known and novel naphthoquinones in the treatment and prophylaxis of Pneumocystis carinii infections, and for the manufacture of medicaments for the treatment and prophylaxis of P.carinii infections, novel formulations containing said compounds, and novel naphthoquinones of formula (VI): <CHEM> wherein R<1><1> and R<1><2> each represent =O and the dotted line represents a double bond between the 2 and 3 positions of the quinone ring, in which case R<1><3> represents a group -OCOR<5>; a group OR<6> or SR<6>; or a group NR<7>R<8>; or the dotted line represents double bonds at the 1,2 and 3,4 positions of the quinol ring and R<1><1>, R<1><2> and R<1><3> each represents a group -OCOR<1><4>, wherein R<1><4> represents an optionally substituted C1-10alkyl group.
申请公布号 DE68928964(D1) 申请公布日期 1999.05.06
申请号 DE1989628964 申请日期 1989.08.15
申请人 THE WELLCOME FOUNDATION LTD., LONDON, GB 发明人 LATTER, VICTORIA, THE WELLCOME RES. LAB., BECKENHAM, KENT BR3 3BS, GB;GUTTERIDGE, WINSTON EDWARD, THE WELLCOME RES. LAB., BECKENHAM, KENT BR3 3BS, GB;HUDSON, ALAN THOMAS, THE WELLCOME RES. LAB., BECKENHAM, KENT BR3 3BS, GB
分类号 A61K31/12;A61K31/122;A61K31/135;A61K31/19;A61K31/215;A61K31/40;A61P13/02;A61P15/00;A61P31/12;A61P33/02;C07C45/00;C07C46/00;C07C50/24;C07C50/32;C07C67/00;C07C69/013;C07C69/017;C07C69/157;C07C69/96;C07C217/12;C07C225/30;C07C229/60;C07C323/22;C07D295/10 主分类号 A61K31/12
代理机构 代理人
主权项
地址